From Breakthrough to Blockbuster: The Business of Biotechnology is an essential resource for students, scientists, investors, entrepreneurs, physicians, policy makers, and all others interested in how new medicines come into being, why the process is so breathtakingly expensive, and how small entrepreneurial ventures can compete in one of the world’s most expensive and heavily regulated industries. Beyond that, the account of how a vast collection of inexperienced, underfunded, and unprofitable small companies have created more life-changing new medicines than the largest global pharmaceutical firms is a David-and-Goliath story well worth reading.
www.thebusinessofbiotechnology.com
